Skip to Content

You are here

Gallagher Lab

Dr. Gallagher’s research aims to develop new neuroimaging biomarkers for the pathology and progression of Parkinson’s disease. In particular, the lab is interested in how disease-related changes in brain connectivity affect cognition in Parkinson’s disease. Currently we are recruiting Parkinson’s and control subjects to participate in a longitudinal MRI study, and are preparing to analyze novel image sequences from the first time point. Data analyses will include looking for associations between standardized cognitive and motor evaluations and brain imaging parameters such as functional and structural connectivity, volumetric studies, and quantification of white matter hyperintensity volume.